Entera Bio Ltd.
(NASDAQ: ENTX)

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

1.480 -

+0.010 (+0.68%)
Range 1.450 - 1.520   (4.83%)
Open 1.480
Previous Close 1.470
Bid Price 1.480
Bid Volume 6,276
Ask Price 1.510
Ask Volume 100
Volume 52,647
Value 51,732
Remark -
Delayed prices. Updated at 30 Jan 2026 03:01.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis